Europe — EMA
Nuvaring (Ethinylestradiol, Etonogestrel)
Ethinylestradiol, the active ingredient in Nuvaring, is a combined estrogen-progestogen contraceptive presented as a vaginal ring for intravaginal use. It prevents pregnancy in women of reproductive age.
Request sourcing
What is Ethinylestradiol, Etonogestrel?
Ethinylestradiol, the active ingredient in Nuvaring, is a combined estrogen-progestogen contraceptive presented as a vaginal ring for intravaginal use. It prevents pregnancy in women of reproductive age. GNH USA supplies Nuvaring as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Nuvaring as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Ethinylestradiol, Etonogestrel used for?
Nuvaring is a combined hormonal contraceptive that works on the reproductive endocrine pathway to prevent pregnancy.
- Contraception: Provides effective, reversible birth control for women seeking a non‑daily method. - Menstrual cycle regulation: Helps achieve more predictable bleeding patterns. - Acne improvement: May reduce acne severity associated with hormonal fluctuations. - Endometriosis symptom relief: Can lessen pelvic pain linked to endometriial lesions. - Menopausal hormone therapy: Provides estrogen‑progestogen support during perimenopause.
What are the side effects of Ethinylestradiol, Etonogestrel?
This



